3,458 results on '"Jennings, Lisa"'
Search Results
2. The Challenge of Integrating Social Justice Content into Social Work Education: Making the Abstract More Concrete
3. Utilization Of A High Risk Heart Failure Clinic To Decrease Heart Failure Admissions
4. Abstract 14206: Cross-Sectional, Exploratory Assessment of Biomarkers in Patients With Decompensated Heart Failure and Underlying Coronary Artery Disease (abide-hf)
5. Pharmacodynamic Effects of Vorapaxar in Patients With and Without Diabetes Mellitus: Results of the OPTIMUS-5 Study
6. Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study.
7. Effects of genetic variation in protease activated receptor 4 after an acute coronary syndrome: Analysis from the TRACER trial
8. Switching from dual antiplatelet therapy with aspirin plus a P2Y12 inhibitor to dual pathway inhibition with aspirin plus vascular-dose rivaroxaban
9. 1157 WITCHING FROM DUAL ANTIPLATELET THERAPY WITH ASPIRIN PLUS A P2Y12 INHIBITOR TO DUAL PATHWAY INHIBITION WITH ASPIRIN PLUS VASCULAR-DOSE RIVAROXABAN: THE SWITCHING ANTI-PLATELET AND ANTI-COAGULANT THERAPY (SWAP-AC) STUDY
10. Translating national level forest service goals to local level land management: carbon sequestration
11. Association of Aspirin Dose and Vorapaxar Safety and Efficacy in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome (from the TRACER Trial)
12. Pharmacodynamics of GPIIb-IIIa Receptor Blockade
13. BLURRED LINES: The boundaries are shifting as grocery stores and meal kits edge in on restaurants
14. Long-Term Care and Life Planning Preferences for Older Gays and Lesbians
15. Fast-casual pizza segment cools: national leaders emerge as the shakeout begins
16. Abstract 20955: Synergistic Effects of Rivaroxaban With Direct-Acting Anti-Platelet Agents on Platelet Reactivity and Thrombin Generation
17. Initiation of rivaroxaban following low molecular weight heparin for thromboprophylaxis after total joint replacement: The Safe, Simple Transitions (SST) study
18. Platelet P2Y12 inhibiting therapy in adjunct to vascular dose of rivaroxaban or aspirin: a pharmacodynamic study of dual pathway inhibition vs. dual antiplatelet therapy
19. A Human Domain Antibody and Lewis b Glycoconjugate That Inhibit Binding of Helicobacter pylori to Lewis b Receptor and Adhesion to Human Gastric Epithelium
20. Building a better bar: casual-dining chains renew focus on craft beers and fresh, seasonal cocktails
21. Bentracimab for Ticagrelor Reversal in Patients Undergoing Urgent Surgery
22. Pharmacodynamic Profiles of Dual-Pathway Inhibition with or without Clopidogrel versus Dual Antiplatelet Therapy in Patients with Atherosclerotic Disease
23. The Early Modern English Sonnet: Ever in Motion. Rémi Vuillemin, Laetitia Sansonetti, and Enrica Zanin, eds. Manchester Spenser. Manchester: Manchester University Press, 2020. x + 230 pp. £80.
24. 10 Pharmacodynamic profiles of aspirin versus dual-pathway inhibition with either aspirin or clopidogrel among patients with stable atherosclerotic disease
25. Regulation of CD40L (CD154) and CD62P (p-selectin) Surface Expression upon GPIIb-IIIa Blockade of Platelets from Stable Coronary Artery Disease Patients
26. Digital demands: restaurants seek new ways to meet consumers' high expectations for mobile features
27. 2014: the year in review
28. Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study
29. Role of Platelets in Atherothrombosis
30. Advances in Antiplatelet Therapy: Agents in Clinical Development
31. Carls Jr., Hardee's ads ditch the bikinis: chains put the focus back on food
32. Identification of Membrane Proteins Mediating the Interaction of Human Platelets
33. SELF-COMPASSION AND LIFE SATISFACTION IN GAY MEN
34. Elevating local concentrations of GPIIb–IIIa antagonists counteracts platelet thrombus stability
35. Abstract 1308: Development and validation of a flow cytometric assay for measuring glycoprotein A repetitions predominant protein GARP target engagement by ABBV-151
36. Hematoma-inspired alginate/platelet releasate/CaPO4 composite: initiation of the inflammatory-mediated response associated with fracture repair in vitro and ex vivo injection delivery
37. Pharmacokinetics and pharmacodynamics of the novel PAR-1 antagonist vorapaxar in patients with end-stage renal disease
38. No differences in the pharmacodynamics and pharmacokinetics of the thrombin receptor antagonist vorapaxar between healthy Japanese and Caucasian subjects
39. Tetraspanins and tumor progression
40. Supplement to: Thrombin-receptor antagonist vorapaxar in acute coronary syndromes.
41. Making connections: industry comes together to share strategies, celebrate leaders at annual MUFSO conference
42. Rewriting the rules: upstart casual-dining concepts challenge the conventions of the segment's biggest brands
43. Catch the consumer: map a new route to win guest traffic
44. Pleasing their palates
45. PHARMACODYNAMIC PROFILES OF DUAL ANTIPLATELET THERAPY VERSUS DUAL PATHWAY INHIBITION IN PATIENTS WITH ATHEROSCLEROTIC DISEASE MANIFESTATIONS
46. PHARMACODYNAMIC EFFECTS OF ADJUNCTIVE CLOPIDOGREL THERAPY IN PATIENTS WITH ATHEROSCLEROTIC DISEASE ON DUAL PATHWAY INHIBITION WITH ASPIRIN AND LOW-DOSE RIVAROXABAN
47. Platelets undergo phosphorylation of Syk at Y525/526 and Y352 in response to pathophysiological shear stress
48. DoorDash to pay $2.5 million to settle District of Columbia driver gratuity lawsuit
49. Thrombo-Inflammation in Cardiovascular Disease : An Expert Consensus Document from the Third Maastricht Consensus Conference on Thrombosis
50. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the Randomized Trial to Evaluate the Relative PROTECTion against Post-PCI Microvascular Dysfunction and Post-PCI Ischemia among Antiplatelet and Antithrombotic Agents - Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.